One year follow-up study of T-cell subsets and incidence of seropositivity for HTLV-I and HTLV-III antibodies in patients treated 'on demand' or sporadically with clotting concentrates

F. Rodeghiero, G. C. Castaman, T. Chisesi, A. De Rossi, O. Dalla Gassa, A. Del Mistro, E. Dini, S. Castronovo, E. Pornaro, L. Chieco-Bianchi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A 1-year follow-up study of the T-cell subset abnormalities was carried out in 16 severe haemophilia A patients, treated 'on demand' with an average amount of 500 U/kg/yr of factor VIII concentrate (group A) and in 15 haemophiliacs or von Willebrand patients treated only sporadically with less than 3000 U of factor VIII and no longer exposed to any other blood component in the 2 years preceding the beginning of the study (group B). In group A, 50% and 70% of patients showed a reduced or inverted T 4/T 8 ratio, respectively, at the beginning and at the end of follow-up. These values were of 30% and 20% in patients of group B, suggesting a long-lasting effect of concentrate therapy on T-cell subsets. The low T 4/T 8 ratio was mainly due to an increase of suppressor cells. None of the patients was found positive for anti HTLV-I, whereas 3 patients, all belonging to the group A, showed antibodies against HTLV-III. Thus, in these patients, HTLV-III seems not to be the only cause of lot T 4/T 8 ratio.

Original languageEnglish
Pages (from-to)665-668
Number of pages4
JournalThrombosis and Haemostasis
Volume54
Issue number3
Publication statusPublished - 1985

Fingerprint

HIV Antibodies
Human T-lymphotropic virus 1
T-Lymphocyte Subsets
Incidence
Factor VIII
Hemophilia A
HIV

ASJC Scopus subject areas

  • Hematology

Cite this

One year follow-up study of T-cell subsets and incidence of seropositivity for HTLV-I and HTLV-III antibodies in patients treated 'on demand' or sporadically with clotting concentrates. / Rodeghiero, F.; Castaman, G. C.; Chisesi, T.; De Rossi, A.; Dalla Gassa, O.; Del Mistro, A.; Dini, E.; Castronovo, S.; Pornaro, E.; Chieco-Bianchi, L.

In: Thrombosis and Haemostasis, Vol. 54, No. 3, 1985, p. 665-668.

Research output: Contribution to journalArticle

Rodeghiero, F. ; Castaman, G. C. ; Chisesi, T. ; De Rossi, A. ; Dalla Gassa, O. ; Del Mistro, A. ; Dini, E. ; Castronovo, S. ; Pornaro, E. ; Chieco-Bianchi, L. / One year follow-up study of T-cell subsets and incidence of seropositivity for HTLV-I and HTLV-III antibodies in patients treated 'on demand' or sporadically with clotting concentrates. In: Thrombosis and Haemostasis. 1985 ; Vol. 54, No. 3. pp. 665-668.
@article{e41698fdda2e4b1080945f7bc4e4580e,
title = "One year follow-up study of T-cell subsets and incidence of seropositivity for HTLV-I and HTLV-III antibodies in patients treated 'on demand' or sporadically with clotting concentrates",
abstract = "A 1-year follow-up study of the T-cell subset abnormalities was carried out in 16 severe haemophilia A patients, treated 'on demand' with an average amount of 500 U/kg/yr of factor VIII concentrate (group A) and in 15 haemophiliacs or von Willebrand patients treated only sporadically with less than 3000 U of factor VIII and no longer exposed to any other blood component in the 2 years preceding the beginning of the study (group B). In group A, 50{\%} and 70{\%} of patients showed a reduced or inverted T 4/T 8 ratio, respectively, at the beginning and at the end of follow-up. These values were of 30{\%} and 20{\%} in patients of group B, suggesting a long-lasting effect of concentrate therapy on T-cell subsets. The low T 4/T 8 ratio was mainly due to an increase of suppressor cells. None of the patients was found positive for anti HTLV-I, whereas 3 patients, all belonging to the group A, showed antibodies against HTLV-III. Thus, in these patients, HTLV-III seems not to be the only cause of lot T 4/T 8 ratio.",
author = "F. Rodeghiero and Castaman, {G. C.} and T. Chisesi and {De Rossi}, A. and {Dalla Gassa}, O. and {Del Mistro}, A. and E. Dini and S. Castronovo and E. Pornaro and L. Chieco-Bianchi",
year = "1985",
language = "English",
volume = "54",
pages = "665--668",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "3",

}

TY - JOUR

T1 - One year follow-up study of T-cell subsets and incidence of seropositivity for HTLV-I and HTLV-III antibodies in patients treated 'on demand' or sporadically with clotting concentrates

AU - Rodeghiero, F.

AU - Castaman, G. C.

AU - Chisesi, T.

AU - De Rossi, A.

AU - Dalla Gassa, O.

AU - Del Mistro, A.

AU - Dini, E.

AU - Castronovo, S.

AU - Pornaro, E.

AU - Chieco-Bianchi, L.

PY - 1985

Y1 - 1985

N2 - A 1-year follow-up study of the T-cell subset abnormalities was carried out in 16 severe haemophilia A patients, treated 'on demand' with an average amount of 500 U/kg/yr of factor VIII concentrate (group A) and in 15 haemophiliacs or von Willebrand patients treated only sporadically with less than 3000 U of factor VIII and no longer exposed to any other blood component in the 2 years preceding the beginning of the study (group B). In group A, 50% and 70% of patients showed a reduced or inverted T 4/T 8 ratio, respectively, at the beginning and at the end of follow-up. These values were of 30% and 20% in patients of group B, suggesting a long-lasting effect of concentrate therapy on T-cell subsets. The low T 4/T 8 ratio was mainly due to an increase of suppressor cells. None of the patients was found positive for anti HTLV-I, whereas 3 patients, all belonging to the group A, showed antibodies against HTLV-III. Thus, in these patients, HTLV-III seems not to be the only cause of lot T 4/T 8 ratio.

AB - A 1-year follow-up study of the T-cell subset abnormalities was carried out in 16 severe haemophilia A patients, treated 'on demand' with an average amount of 500 U/kg/yr of factor VIII concentrate (group A) and in 15 haemophiliacs or von Willebrand patients treated only sporadically with less than 3000 U of factor VIII and no longer exposed to any other blood component in the 2 years preceding the beginning of the study (group B). In group A, 50% and 70% of patients showed a reduced or inverted T 4/T 8 ratio, respectively, at the beginning and at the end of follow-up. These values were of 30% and 20% in patients of group B, suggesting a long-lasting effect of concentrate therapy on T-cell subsets. The low T 4/T 8 ratio was mainly due to an increase of suppressor cells. None of the patients was found positive for anti HTLV-I, whereas 3 patients, all belonging to the group A, showed antibodies against HTLV-III. Thus, in these patients, HTLV-III seems not to be the only cause of lot T 4/T 8 ratio.

UR - http://www.scopus.com/inward/record.url?scp=0022376105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022376105&partnerID=8YFLogxK

M3 - Article

C2 - 3003954

AN - SCOPUS:0022376105

VL - 54

SP - 665

EP - 668

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 3

ER -